Promising Results in Early Trial of Novel MS Treatment
11:25 minutes
Subscribe to Science Friday
Reporting in the journal Science Translational Medicine, researchers say a new method for essentially resetting the immune systems of patients with multiple sclerosis appears to be safe. Study co-author Stephen D. Miller, of Northwestern University, describes the novel approach tested in this small, phase 1 clinical trial and explains how it might one day also be used to treat other autoimmune diseases such as type 1 diabetes.
Segment Guests
Stephen D. Miller
Stephen D. Miller is professor of microbiology-immunology at the Northwestern University Feinberg School of Medicine, and director of Immunobiology Center at Northwestern University in Chicago, Illinois.
Meet the Producer
About Annette Heist
Annette Heist is an audio producer and editor based near Philadelphia, PA.